Covid-19

Community Deployment of Neutralising Monoclonal Antibodies (nMAB) or Antivirals for non-hospitalised patients with COVID-19

Overview: During this webinar our colleagues from the National Antiviral Service (NAVS) will focus on the community deployment of Neutralising Monoclonal Antibodies (nMAB) or Antivirals for non-hospitalised patients with COVID-19

Learning outcomes: The following areas will be addressed during the webinar:
• What the treatments are
• Who is eligible for routine treatment
• How people are identified
• How treatment is delivered by the National Antiviral Service
• Who should be referred and who should not
• How to make an appropriate referral

Speakers: Alana Adams, Principal Pharmacist, and Dr Laurance Gray Clinical Pharmacologist
and Consultant Physician at National Antiviral Service (NAVS)

Facilited by: Dr Chris Price, Head of RSU.

Transcript 

Recorded: April 2022 Duration: 52 minutes